Table 2. Categorical agreement and errors for the tested isolates.
| Antibiotic | Isolates resistant by BMD | Isolates susceptible by BMD | Isolates intermediate by BMD | Total replicates | Very major error rate | Major error rate | Number of minor errors | Categorical agreement | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Susceptible by qPCR | Resistant by qPCR | Susceptible by qPCR | Resistant by qPCR | Susceptible by qPCR | Resistant by qPCR | ||||||
| Ciprofloxacin | 1 | 89 | 47 | 3 | 0 | 4 | 144 | 1.1% | 6.0% | 0 | 97.2% |
| Gentamicin | 1 | 52 | 42 | 1 | 1 | 4 | 102 | 3.7% | 2.3% | 1 | 96.1% |
| Imipenem | 1 | 50 | 47 | 1 | 1 | 2 | 102 | 2.0% | 2.1% | 1 | 97.1% |
| Oxacillin | 1 | 11 | 7 | 1 | 0 | 0 | 20 | 8.3% | 12.5% | 0 | 90.0% |
| Ampicillin | 0 | 12 | 10 | 0 | 0 | 0 | 22 | 0.0% | 0.0% | 0 | 100.0% |
| Vancomycin | 2 | 8 | 31 | 1 | 0 | 0 | 42 | 20.0% | 3.1% | 0 | 92.9% |
| Overall | 7 | 222 | 184 | 7 | 2 | 10 | 432 | 3.1% | 3.7% | 2 | 96.3% |